Related references
Note: Only part of the references are listed.Old Dog, New Trick: A Tumor-Intrinsic Role for PD-1 in Chemoresistant Tumor Subclones
Ryan C. Augustin et al.
CLINICAL CANCER RESEARCH (2023)
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells
Lily L. Remsing Rix et al.
SCIENCE SIGNALING (2022)
Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
Chenxin Li et al.
PHARMACEUTICALS (2022)
The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion
Yoonki Hong et al.
SCIENTIFIC REPORTS (2022)
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
Katsuhiro Yoshikawa et al.
BMC CANCER (2021)
Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling
Yingyan Wang et al.
CELL DEATH & DISEASE (2021)
Role of cancer-associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non-small cell lung cancer
Congcong Chen et al.
ONCOLOGY LETTERS (2021)
The Role of Tumor Inflammatory Microenvironment in Lung Cancer
Zhaofeng Tan et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Role of Cancer-Associated Fibroblasts in Tumor Progression
Rushikesh S. Joshi et al.
CANCERS (2021)
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
He-Ming Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
In search of definitions: Cancer-associated fibroblasts and their markers
Martin Nurmik et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Cancer chemoresistance and therapeutic strategies targeting tumor microenvironment
Gayathri Heenatigala Palliyage et al.
SCIENCEASIA (2020)
Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
Go J. Yoshida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer
Yanhui Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
Lei Shang et al.
FRONTIERS IN ONCOLOGY (2019)
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
Koji Teramoto et al.
LUNG CANCER (2019)
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Hua Guo et al.
CANCER CELL INTERNATIONAL (2019)
Causes of death in long-term survivors of non-small cell lung cancer: A regional Surveillance, Epidemiology, and End Results study
Amaraja A. Kanitkar et al.
ANNALS OF THORACIC MEDICINE (2018)
Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling
Yanmei Yi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
A peek into cancer-associated fibroblasts: origins, functions and translational impact
Valerie S. LeBleu et al.
DISEASE MODELS & MECHANISMS (2018)
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features
Sharathchandra Arandkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
Yun Che et al.
CELL DEATH & DISEASE (2018)
Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
Jing Ren et al.
THERANOSTICS (2018)
HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis
Xusheng Ding et al.
CELL DEATH & DISEASE (2018)
Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response
Justin D. Middleton et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
Lusheng Wei et al.
CELL DEATH & DISEASE (2018)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
Lihui Wang et al.
CELL DEATH & DISEASE (2017)
Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression
Nobuhiro Kanaji et al.
RESPIRATORY RESEARCH (2017)
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
Leilei Tao et al.
SCIENTIFIC REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita et al.
MOLECULAR THERAPY (2015)
Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth
Akiko Takahashi et al.
ONCOTARGET (2015)
Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform
Li Ying et al.
PLOS ONE (2015)
Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
Kamolporn Amornsupak et al.
BMC CANCER (2014)
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
Gvantsa Kharaishvili et al.
CANCER CELL INTERNATIONAL (2014)
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
Fiorenza Lotti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase-Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells
Ann-Charlotte Johansson et al.
MOLECULAR CANCER RESEARCH (2012)
The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas
Feng Li et al.
MEDICAL ONCOLOGY (2011)
Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer
Roya Navab et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts
Magdalena Ksiazkiewicz et al.
IMMUNOBIOLOGY (2010)
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
WY Chen et al.
CELL (2005)
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer
K Yoh et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
